Does BPC-157 have antidepressant or anti-anxiety effects?

BPC-157, a synthetic pentadecapeptide, has shown signals of antidepressant-like and anxiolytic-like effects in animal models, but there is no direct human clinical evidence to establish it as an effective treatment for depression or anxiety. The research suggests that BPC-157 may modulate various neurotransmitter systems and influence the gut-brain axis, which could theoretically be related to mood regulation. However, it is important to note that the provided sources do not offer direct evidence or studies to support the claim that BPC-157 has proven antidepressant or anti-anxiety effects in humans [1].

What the AI assistants say

The AI assistants collectively agree that BPC-157 has shown antidepressant-like and anxiolytic-like effects in animal models, particularly in rodents. They highlight the peptide’s potential to modulate dopamine, serotonin, GABA, glutamate, and nitric oxide systems, as well as its influence on the gut-brain axis [1]. The AI assistants also note the lack of human clinical evidence, emphasizing that there are no published clinical trials for mood or anxiety, and no FDA-approved dosing guidelines exist for these conditions [1]. They differ in the level of detail provided regarding the mechanisms and the strength of the evidence from animal studies, but overall, they concur on the absence of human evidence supporting BPC-157’s use for depression or anxiety.

What the research actually shows

The research corpus provides a more nuanced view. While it acknowledges the potential interactions of BPC-157 with adrenergic and dopaminergic systems, which are implicated in stress response and could influence mood and anxiety, it does not offer direct evidence for antidepressant or anti-anxiety effects [15]. The research suggests that BPC-157 may have an impact on stress-related conditions and brain-gut communication, but this is not the same as directly stating proven effects on depression or anxiety [1]. The sources indicate that BPC-157 “positively affects other consequences of stress injury” such as “a strong decrease of the stress-induced thymolymphatic involution and adrenal gland hypertrophy” [1], but again, this does not specifically address anxiety or depression.

The contrast between the AI assistants’ synthesis and the research corpus is that the AI assistants focus on the potential mechanisms and the preclinical evidence from animal studies, while the research corpus emphasizes the lack of direct evidence for BPC-157’s effects on depression or anxiety in humans. The research corpus does not dismiss the potential of BPC-157 but cautions against drawing conclusions from the available data.

Bottom line:

While BPC-157 has shown signals of antidepressant-like and anxiolytic-like effects in animal models, there is no direct human clinical evidence to support its use for treating depression or anxiety.

References

  1. Beneficial effect of a novel pentadecapeptide BPC 157 on — Predrag Sikirić
  2. Hepatoprotective effect of BPC 157, A 15-aminoacid peptide — Predrag Sikiric
  3. Long-lasting cytoprotection after pentadecapeptide BPC 157 — Predrag Sikiric
  4. Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
  5. Pentadecapeptide BPC 157 Interactions with Adrenergic and — Vjekoslav Jagic
  6. Pentadecapeptide BPC 157 and its effects on a NSAID toxicity — Spomenko Ilic
  7. Pentadecapeptide BPC 157, Cimetidine, Ranitidine — Predrag Sikiric
  8. Portal hypertension and liver lesions in chronically alcohol — Ingrid Prkacin
  9. The pharmacological properties of the novel peptide BPC 157 — P Sikiric(Affiliation Department of Pharmacology, Medical
  10. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
  11. Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor

Continue your research

Part of our BPC-157: Brain & Nervous System guide.

Related topics:

PeptideXR is an open-access research project of Morpheus Institute of Technology — an AI + bioinformatics platform company advancing precision health.